Q32 Bio earnings were $33.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest QTTB earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$7.6M, down 113.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, QTTB reported annual earnings of $29.8M, with -162.5% growth. The next QTTB earnings date is Aug 5, 2026.
Q32 Bio (NASDAQ: QTTB) reported Q1 2026 earnings per share (EPS) of -$0.54, up 40% year over year. Total QTTB earnings for the quarter were -$7.61 million. In the same quarter last year, Q32 Bio's earnings per share (EPS) was -$0.90.
The next QTTB earnings date is Aug 5, 2026. Add QTTB to your watchlist to be reminded of Q32 Bio's next earnings date.
Is Q32 Bio profitable or losing money?
As of the last Q32 Bio earnings report, Q32 Bio is currently profitable. Q32 Bio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $33.24 million, a 155.6% decrease year over year.
What was QTTB's earnings growth in the past year?
As of Q32 Bio's earnings date in Q3 2026, Q32 Bio's earnings has grown year over year. QTTB earnings in the past year totalled $33.24 million.
What are Q32 Bio's earnings expectations?
The current EPS estimate for Q32 Bio's earnings report in Aug 5, 2026 is -$0.57.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.